[vc_row][vc_column][vc_column_text]
Hearts transplants, or cardiac transplantation, is a surgical transplant procedure performed on patients with end-stage heart failure or severe coronary artery disease. The most common procedure is to take a working heart from a recently deceased organ donor (allograft) and implant it into the patient. The patient’s own heart may either be removed (orthotopic procedure) or, less commonly, left in to support the donor heart (heterotopic procedure); both are controversial solutions to one of the most enduring human ailments. Post-operation survival periods now average 15 years.
Heart transplant surgery may NOT be recommended for patients who have : –
The doctor may also recommend against a heart transplant if there is concern that the patient will not be able to comply with the many hospital and doctor’s office visits, tests, and medications needed to keep the new heart healthy.
Risks Risks for any anesthesia are : –
Risks for any surgery are : –
Risks of transplant include : –
Expectations after surgery in India Heart transplant prolongs the life of a patient who would otherwise die. About 80% of heart transplants are alive 2 years after the operation. The main problem, as with other transplants, is graft rejection. If rejection can be controlled, the patient’s survival can be increased to over 10 years.
Drugs that prevent transplant rejection must be taken for the rest of the patient’s life. Normal activities can resume as soon as the patient feels well enough and after consulting with the doctor. However, vigorous physical activities should be avoided.The major problems are the same for all major organ transplants : –
Finding a donor can be difficult. In heart transplantation, the healthy heart must come from a person who recently died or is on life-support and is brain dead. This is different than a kidney transplant, because a kidney may be donated by a living person.
Timing is very important because there is no good way to keep a donor heart alive for long periods of time. A person in need of a heart transplant may be kept alive on artificial heart devices for longer and longer periods of time. However, artificial hearts also have major risks. While some of these devices are fully approved, others are still considered experimental.
Fighting rejection is an ongoing process. The body’s immune system considers the transplanted organ an infection and fights it. For this reason, organ transplant patients must take drugs such as cyclosporine and corticosteroids that suppress the body’s immune response. The downside of these drugs is that they weaken the body’s natural defense against infection.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_message style=”square” message_box_color=”mulled_wine”]
[/vc_message][/vc_column][/vc_row]